London : Drug manufacturer Moderna has claimed that its Kovid-19 vaccine will keep immunity in your body for at least a year to protect you from corona. The company said that its vaccine-making technology is so powerful that it will also be effective on new variants of the corona virus. Moderna’s chief executive officer, Stephanie Bansel, said that our messenger RNA vaccine technology is extremely state-of-the-art. Our vaccine name is Messenger RNA-1273. This vaccine contains a synthetic messenger RNA, which mimics the outer layer of the corona virus. This develops immunity against the corona virus in the body. When the corona virus attacks in the body, the body neutralizes or weakens the corona virus attack through a pre-prepared immunity. The company said in December that it would test its vaccine on all types of Corona variants and strains. Now the company has claimed that its vaccine is effective on every variant of corona virus present in the world.
The company has claimed that it will produce 60 crore to 100 crore vaccine doses by the end of 2021. According to the advance purchase agreement and the demand made by the governments, Moderna will generate 11.7 billion dollars or Rs 85,837 crore in the next year from its vaccine. Moderna CEO Stephanie said, “I sincerely hope that our team will prepare 60 million vaccine doses comfortably.” We will be able to give it to the whole world at the right time.
We will try and make more dose by giving it to the world. However, according to information received from sources, IIL is currently in talks to bring Moderna’s vaccine to India. However, only the possibility of whether this can happen or not is being discussed and the discussion is also only in the initial stages. There is news that Moderna wants to make her own vaccine in India. If vaccines like Moderna and Pfizer are made in India with the help of a company, then their price will be less.
Sources have said that it is easy to produce the messenger RNA technology vaccines in India. If the talks are successful, then the Moderna vaccine will start production in India within 2-3 months. However, sources say that at the present time, it is very impractical to bring Pfizer and Moderna to India. The disease conditions in India are very different from other countries. The UK regulatory authority has approved the third vaccine of Kovid-19 on Friday. Which is developed by Mordana Company. It may take a week to reach the market. The UK government has already placed an order for 70,00,000 doses to Mordana. According to the information, the Moderna vaccine was tested on more than 30 thousand people. Its results have been seen to be about 95 percent safe. Moderna’s vaccine works like a Pfizer and BioNotech vaccine. It has to be kept at -20 ° C temperature.